Viewing Study NCT03417895


Ignite Creation Date: 2025-12-24 @ 2:07 PM
Ignite Modification Date: 2026-02-23 @ 1:11 AM
Study NCT ID: NCT03417895
Status: COMPLETED
Last Update Posted: 2024-08-07
First Post: 2018-01-08
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-04-20
Start Date Type: ACTUAL
Primary Completion Date: 2021-08-04
Primary Completion Date Type: ACTUAL
Completion Date: 2021-08-04
Completion Date Type: ACTUAL
First Submit Date: 2018-01-08
First Submit QC Date: None
Study First Post Date: 2018-01-31
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-04-12
Results First Submit QC Date: None
Results First Post Date: 2024-08-07
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-02-25
Last Update Post Date: 2024-08-07
Last Update Post Date Type: ACTUAL